These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2872801)

  • 41. Pharmacological tolerance to alpha 1-adrenergic receptor antagonism mediated by terazosin in humans.
    Vincent J; Dachman W; Blaschke TF; Hoffman BB
    J Clin Invest; 1992 Nov; 90(5):1763-8. PubMed ID: 1358918
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Experience with terazosin administered in combination with other antihypertensive agents.
    Chrysant SG
    Am J Med; 1986 May; 80(5B):55-61. PubMed ID: 2872808
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Haemodynamic effects of dicentrine, a novel alpha 1-adrenoceptor antagonist: comparison with prazosin in spontaneously hypertensive and normotensive Wistar-Kyoto rats.
    Yu SM; Hsu SY; Ko FN; Chen CC; Huang YL; Huang TF; Teng CM
    Br J Pharmacol; 1992 Aug; 106(4):797-801. PubMed ID: 1356567
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of urapidil, clonidine, prazosin and propranolol on autonomic nerve activity, blood pressure and heart rate in anaesthetized rats and cats.
    Sanders KH; Jurna I
    Eur J Pharmacol; 1985 Apr; 110(2):181-90. PubMed ID: 3987812
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of trimazosin and prazosin on blood pressure and on pressor responses to phenylephrine in rats.
    Constantine JW; Lebel W; Weeks R
    Am Heart J; 1983 Nov; 106(5 Pt 2):1216-21. PubMed ID: 6637787
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Structure-activity relationships in prazosin-related compounds. 2. Role of the piperazine ring on alpha-blocking activity.
    Giardinà D; Gulini U; Massi M; Piloni MG; Pompei P; Rafaiani G; Melchiorre C
    J Med Chem; 1993 Mar; 36(6):690-8. PubMed ID: 8096245
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacokinetic and pharmacodynamic modelling of arterial haemodynamic effects of terazosin in healthy volunteers.
    Campanero MA; Sádaba B; Muñoz-Juarez MJ; Quetglas EG; Azanza JR
    Clin Drug Investig; 2008; 28(3):139-47. PubMed ID: 18266399
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hypotensive effects of eugenosedin-A with serotonin, alpha- and beta-adrenoceptor antagonistic activities in spontaneously hypertensive and normotensive rats.
    Shen KP; Chiu CC; Chen SJ; Chen IJ; Wu BN
    Pharmacology; 2004 Jun; 71(2):91-101. PubMed ID: 15118348
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Baroreceptor mediated blood pressure regulation is not affected during dose dependent inhibition of prostatic contractions by terazosin.
    Pawar A; Fahim M
    Indian J Physiol Pharmacol; 2004 Oct; 48(4):419-27. PubMed ID: 15907050
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The safety and efficacy of terazosin in the treatment of essential hypertension in blacks.
    Saunders E
    Am Heart J; 1991 Sep; 122(3 Pt 2):936-42. PubMed ID: 1678925
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Beneficial effects of non-quinazoline α
    Kubacka M; Kotańska M; Szafarz M; Pociecha K; Waszkielewicz AM; Marona H; Filipek B; Mogilski S
    Nutr Metab Cardiovasc Dis; 2019 Jul; 29(7):751-760. PubMed ID: 31133498
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antihypertensive effects of doxazosin in systemic hypertension and comparison with terazosin.
    Hayduk K; Schneider HT
    Am J Cardiol; 1987 May; 59(14):95G-98G. PubMed ID: 2884860
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Studies on the hypotensive response to atropine in hypertensive rats.
    Abraham S; Cantor EH; Spector S
    J Pharmacol Exp Ther; 1981 Sep; 218(3):662-8. PubMed ID: 6115051
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of withdrawal of terazosin therapy in patients with hypertension.
    Ruoff G
    Am J Med; 1986 May; 80(5B):35-41. PubMed ID: 2872805
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cumulative experience with terazosin administered in combination with diuretics.
    Rudd P
    Am J Med; 1986 May; 80(5B):49-54. PubMed ID: 2872807
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparative first dose effects of prazosin and tiodazosin (BL-5111) in spontaneously hypertensive rats.
    Roebel LE; Florczyk AP; Buyniski JP
    Res Commun Chem Pathol Pharmacol; 1979 Jan; 23(1):29-35. PubMed ID: 441514
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of antihypertensive and lipid actions of terazosin and atenolol in essential hypertension.
    Silke B; Guy S; Humphreys JE
    J Hum Hypertens; 1992 Jun; 6(3):221-5. PubMed ID: 1352828
    [TBL] [Abstract][Full Text] [Related]  

  • 58. General pharmacology of the novel centrally acting antihypertensive agent moxonidine.
    Armah BI; Hofferber E; Stenzel W
    Arzneimittelforschung; 1988 Oct; 38(10):1426-34. PubMed ID: 3196383
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficacy of terazosin as an antihypertensive agent.
    Luther RR; Glassman HN; Jordan DC; Sperzel WD
    Am J Med; 1986 May; 80(5B):73-6. PubMed ID: 2872811
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hemodynamic and neuroendocrine responses to acute and chronic alpha-adrenergic blockade with prazosin and phenoxybenzamine.
    Mulvihill-Wilson J; Gaffney FA; Pettinger WA; Blomqvist CG; Anderson S; Graham RM
    Circulation; 1983 Feb; 67(2):383-93. PubMed ID: 6129077
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.